| Assessment of vancomycin pharmacokinetics and dose regimen optimisation in preterm neonates M Mulubwa, HA Griesel, P Mugabo, R Dippenaar, L van Wyk Drugs in R&D 20, 105-113, 2020 | 23 | 2020 |
| Development and validation of high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method for determination of tenofovir in small volumes of human plasma M Mulubwa, M Rheeders, L Du Plessis, A Grobler, M Viljoen Journal of Chromatography & Separation Techniques 6 (7), 1, 2015 | 18 | 2015 |
| Population pharmacokinetic modelling of pyrazinamide and pyrazinoic acid in patients with multi-drug resistant tuberculosis P Mugabo, M Mulubwa European Journal of Drug Metabolism and Pharmacokinetics 44, 519-530, 2019 | 16 | 2019 |
| Amount of cycloserine emanating from terizidone metabolism and relationship with hepatic function in patients with drug-resistant tuberculosis M Mulubwa, P Mugabo Drugs in R&D 19, 289-296, 2019 | 13 | 2019 |
| Steady‐state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug‐resistant tuberculosis M Mulubwa, P Mugabo British Journal of Clinical Pharmacology 85 (9), 1946-1956, 2019 | 13 | 2019 |
| Antimicrobial activity and potency of Cassia Abbreviata Oliv stem bark extracts M Mulubwa, S Prakash International Journal of Pharmacy and Pharmaceutical Sciences 7 (6), 426-428, 2015 | 12 | 2015 |
| Access to chronic medicines: patients’ preferences for a last kilometre medicine delivery service in Cape Town, South Africa S Adams, M Mulubwa, M van Huyssteen, A Bheekie BMC Family Practice 22, 1-12, 2021 | 11 | 2021 |
| Relationship between cardiorespiratory fitness and anthropometric variables among school-going adolescents in Nigeria OS Olawale, M Mwila, YME Marie, TA Lamina The Anthropologist 29 (1), 65-72, 2017 | 10 | 2017 |
| Population pharmacokinetic-pharmacodynamic modeling of acetaminophen in preterm neonates with hemodynamically significant patent ductus arteriosus K Sridharan, E Al Ansari, M Mulubwa, AP Raju, A Al Madhoob, M Al Jufairi, ... European Journal of Pharmaceutical Sciences 167, 106023, 2021 | 9 | 2021 |
| Associations between plasma tenofovir concentration and renal function markers in HIV-infected women M Mulubwa, M Rheeders, C Fourie, M Viljoen Southern African Journal of HIV Medicine 17 (1), 1-6, 2016 | 9 | 2016 |
| Analysis of terizidone in plasma using HPLC‐UV method and its application in a pharmacokinetic study of patients with drug‐resistant tuberculosis M Mulubwa, P Mugabo Biomedical Chromatography 32 (11), e4325, 2018 | 7 | 2018 |
| AI can help to tailor drugs for Africa—but Africans should lead the way G Turon, M Njoroge, M Mulubwa, M Duran-Frigola, K Chibale Nature 628 (8007), 265-267, 2024 | 5 | 2024 |
| Ethionamide population pharmacokinetics/pharmacodynamics and therapeutic implications in South African adult patients with drug‐resistant tuberculosis P Mugabo, M Mulubwa British Journal of Clinical Pharmacology 87 (10), 3863-3870, 2021 | 5 | 2021 |
| Integrating Pharmacokinetic–Pharmacodynamic Modeling and Physiologically Based Pharmacokinetic Modeling to Optimize Human Dose Predictions for Plasmodium falciparum Malaria: a … D Redhi, M Mulubwa, L Gibhard, K Chibale Antimicrobial Agents and Chemotherapy 67 (5), e01345-22, 2023 | 3 | 2023 |
| Parental reporting of adverse drug reactions in South Africa: An online survey S Pillay, M Mulubwa, M Viljoen African Journal of Primary Health Care & Family Medicine 13 (1), 2880, 2021 | 3 | 2021 |
| Bone turnover markers in HIV-infected women on tenofovir-based antiretroviral therapy M Mulubwa, M Viljoen, IM Kruger, HS Kruger, M Rheeders AOSIS, 2017 | 3 | 2017 |
| Population pharmacokinetics and dose optimization of vancomycin in critically Ill children K Sridharan, MY Abbasi, M Mulubwa European Journal of Drug Metabolism and Pharmacokinetics 46 (4), 539-546, 2021 | 2 | 2021 |
| Model-Informed Approaches to Optimizing Therapeutics in the African Patient Populations M Mulubwa, K Chibale Clinical pharmacology and therapeutics, 2024 | 1 | 2024 |
| Sensitive ultra-performance liquid chromatography tandem mass spectrometry method for determination of cycloserine in plasma for a pharmacokinetics study M Mulubwa, P Mugabo Journal of chromatographic science 57 (6), 560-564, 2019 | 1 | 2019 |
| Dose-fractionation studies of a Plasmodium phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria L Gibhard, M Njoroge, M Mulubwa, N Lawrence, D Smith, J Duffy, ... Antimicrobial Agents and Chemotherapy 68 (10), e00842-24, 2024 | | 2024 |
Michelle ViljoenSenior Lecturer and Researcher, School of Pharmacy, North-West University在 nwu.ac.za 的电子邮件经过验证
